Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC
ClinicalTrials.gov study NCT04405674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
ClinicalTrials.gov study NCT06585059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy
ClinicalTrials.gov study NCT05314296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00830245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detecting EGFR T790M Mutations From Circulating Tumor Cells
ClinicalTrials.gov study NCT01734915. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation
ClinicalTrials.gov study NCT00861627. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
ClinicalTrials.gov study NCT06156527. IPD Sharing: NO. Countries: 1. Publications: 0.
NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.
ClinicalTrials.gov study NCT02347839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
ClinicalTrials.gov study NCT05258279. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07028489. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05267288. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
ClinicalTrials.gov study NCT04591002. IPD Sharing: NO. Countries: 1. Publications: 0.
Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01623102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy
ClinicalTrials.gov study NCT00657098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
ClinicalTrials.gov study NCT04370860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
ClinicalTrials.gov study NCT04868877. IPD Sharing: NO. Countries: 9. Publications: 0.
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression
ClinicalTrials.gov study NCT02431169. IPD Sharing: NO. Countries: 1. Publications: 0.
Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases
ClinicalTrials.gov study NCT07304739. IPD Sharing: NO. Countries: 1. Publications: 0.
GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
ClinicalTrials.gov study NCT03618667. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients
ClinicalTrials.gov study NCT02914990. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.